Clinical Trials Browser

Phase 3 × glasdegib × Other hematologic neoplasm × Clear all

NCT04842604 2023-12-18

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

Phase 3 Completed

14 enrolled 11 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT03416179 2023-04-21

BRIGHT AML1019

Phase 3 Completed

730 enrolled 35 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04093505 2022-07-01

GnG

Phase 3 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute